Chapter 65 Stroke
Leys et al.
The ESC Textbook of Acute and Intensive Cardiac Care 2010;1:med-9780199584314-chapter-med-9780199584314-chapter.
ABSTRACT
| FULL TEXT
Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Patrono et al.
Chest 2008;133:199S-233S.
ABSTRACT
| FULL TEXT
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Schulman et al.
Chest 2008;133:257S-298S.
ABSTRACT
| FULL TEXT
Maintaining Therapeutic Anticoagulation: The Importance of Keeping "Within Range"
Lane and Lip
Chest 2007;131:1277-1279.
FULL TEXT
Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers
Capucci et al.
J Am Coll Cardiol 2005;46:1913-1920.
ABSTRACT
| FULL TEXT
Risks of Oral Anticoagulant Therapy With Increasing Age
Torn et al.
Arch Intern Med 2005;165:1527-1532.
ABSTRACT
| FULL TEXT
Rate Control Is Preferable to Rhythm Control in the Majority of Patients With Atrial Fibrillation
Falk
Circulation 2005;111:3141-3150.
FULL TEXT
In defence of current treatment options: where are we now?
Voller
Eur Heart J Suppl 2005;7:E4-E9.
FULL TEXT
Maximizing current treatment options: exploring psychological barriers to change
Murphy
Eur Heart J Suppl 2005;7:E10-E14.
FULL TEXT
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation: A Randomized Trial
SPORTIF Executive Steering Committee for the SPORT
JAMA 2005;293:690-698.
ABSTRACT
| FULL TEXT
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Patrono et al.
Chest 2004;126:234S-264S.
ABSTRACT
| FULL TEXT
Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Levine et al.
Chest 2004;126:287S-310S.
ABSTRACT
| FULL TEXT
The Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral Hemorrhage
Rosand et al.
Arch Intern Med 2004;164:880-884.
ABSTRACT
| FULL TEXT
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation: An Individual Patient Meta-analysis
van Walraven et al.
JAMA 2002;288:2441-2448.
ABSTRACT
| FULL TEXT
Effects of Anticoagulation on Infarct Size and Clinical Outcome in Acute Cardioembolic Stroke
Wakita et al.
ANGIOLOGY 2002;53:551-556.
ABSTRACT
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke
Smith et al.
Neurology 2002;59:193-197.
ABSTRACT
| FULL TEXT
Prothrombotic markers in atrial fibrillation: what is new?
Al-Saady and Sopher
Eur Heart J 2001;22:1635-1639.
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation
Taylor et al.
BMJ 2001;322:321-326.
ABSTRACT
| FULL TEXT
Managing Oral Anticoagulant Therapy
Ansell et al.
Chest 2001;119:22S-38S.
FULL TEXT
Platelet-Active Drugs : The Relationships Among Dose, Effectiveness, and Side Effects
Patrono et al.
Chest 2001;119:39S-63S.
FULL TEXT
Hemorrhagic Complications of Anticoagulant Treatment
Levine et al.
Chest 2001;119:108S-121S.
FULL TEXT
Safety and Cost of Low-Molecular-Weight Heparin as Bridging Anticoagulant Therapy in Subacute Cerebral Ischemia
Kalafut et al.
Stroke 2000;31:2563-2568.
ABSTRACT
| FULL TEXT
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: A genetic and pathologic study
Rosand et al.
Neurology 2000;55:947-951.
ABSTRACT
| FULL TEXT
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation : A Multicenter, Prospective, Randomized Trial
Yamaguchi
Stroke 2000;31:817-821.
ABSTRACT
| FULL TEXT
Left atrial appendage: structure, function, and role in thromboembolism
Al-Saady et al.
Heart 1999;82:547-554.
ABSTRACT
| FULL TEXT
Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke
Kapral and Silver
CMAJ 1999;161:989-996.
ABSTRACT
| FULL TEXT
Thromboembolism after atrioventricular node ablation and pacing: long term follow up
Gasparini et al.
Heart 1999;82:494-498.
ABSTRACT
| FULL TEXT
Is Carotid Endarterectomy Appropriate for Asymptomatic Stenosis?: No
Chaturvedi
Arch Neurol 1999;56:879-881.
FULL TEXT
Managing atrial fibrillation in elderly people
English and Channer
BMJ 1999;318:1088-1089.
FULL TEXT
Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation
Gage et al.
Stroke 1998;29:1083-1091.
ABSTRACT
| FULL TEXT
Thrombosis and Hemostasis in Cardiology: Review of Pathophysiology and Clinical Practice (Part I)
Baker
CLIN APPL THROMB HEMOST 1998;4:51-75.
ABSTRACT
Warfarin Use Among Patients With Atrial Fibrillation
Brass et al.
Stroke 1997;28:2382-2389.
ABSTRACT
| FULL TEXT
Atrial Fibrillation and Stroke Prevention With Warfarin in the Long-term Care Setting
Gurwitz et al.
Arch Intern Med 1997;157:978-984.
ABSTRACT
Status of Antithrombotic Therapy for Patients With Atrial Fibrillation in University Hospitals
Albers et al.
Arch Intern Med 1996;156:2311-2316.
ABSTRACT
Paroxysmal Atrial Fibrillation: A Common but Neglected Entity
Aboaf and Wolf
Arch Intern Med 1996;156:362-367.
ABSTRACT
Thoracoscopic Obliteration of the Left Atrial Appendage: Potential for Stroke Reduction?
Odell et al.
Ann. Thorac. Surg. 1996;61:565-569.
ABSTRACT
| FULL TEXT
Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients With Atrial Fibrillation
Blackshear and Odell
Ann. Thorac. Surg. 1996;61:755-759.
ABSTRACT
| FULL TEXT
Cost-effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients With Nonvalvular Atrial Fibrillation
Gage et al.
JAMA 1995;274:1839-1845.
ABSTRACT
Cardiovascular Disease
Gore and Dalen
JAMA 1995;273:1662-1664.
ABSTRACT
Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation: Analysis and Implications
Feinberg et al.
Arch Intern Med 1995;155:469-473.
ABSTRACT
